PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
0.46%
Revenue growth below 50% of CRWV's 23.55%. Michael Burry would check for competitive disadvantage risks.
-57.94%
Cost reduction while CRWV shows 19.16% growth. Joel Greenblatt would examine competitive advantage.
8.03%
Gross profit growth below 50% of CRWV's 25.15%. Michael Burry would check for structural issues.
7.54%
Margin expansion exceeding 1.5x CRWV's 1.30%. David Dodd would verify competitive advantages.
16.29%
R&D change of 16.29% while CRWV maintains spending. Bruce Berkowitz would investigate effectiveness.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
14.52%
Similar operating expenses growth to CRWV's 17.97%. Walter Schloss would investigate norms.
1.56%
Total costs growth less than half of CRWV's 18.28%. David Dodd would verify sustainability.
No Data
No Data available this quarter, please select a different quarter.
142.31%
D&A growth above 1.5x CRWV's 26.15%. Michael Burry would check for excessive investment.
11.46%
EBITDA growth below 50% of CRWV's 33.05%. Michael Burry would check for structural issues.
13.60%
EBITDA margin growth exceeding 1.5x CRWV's 7.69%. David Dodd would verify competitive advantages.
-1.53%
Operating income decline while CRWV shows 169.93% growth. Joel Greenblatt would examine position.
-1.97%
Operating margin decline while CRWV shows 156.60% growth. Joel Greenblatt would examine position.
-9.09%
Both companies reducing other expenses. Martin Whitman would check industry patterns.
-2.37%
Pre-tax income decline while CRWV shows 9.63% growth. Joel Greenblatt would examine position.
-2.82%
Pre-tax margin decline while CRWV shows 26.86% growth. Joel Greenblatt would examine position.
-2.58%
Tax expense reduction while CRWV shows 3.78% growth. Joel Greenblatt would examine advantage.
-2.26%
Net income decline while CRWV shows 7.67% growth. Joel Greenblatt would examine position.
-2.70%
Net margin decline while CRWV shows 25.27% growth. Joel Greenblatt would examine position.
-8.33%
EPS decline while CRWV shows 23.08% growth. Joel Greenblatt would examine position.
-8.33%
Diluted EPS decline while CRWV shows 23.08% growth. Joel Greenblatt would examine position.
6.62%
Share count reduction exceeding 1.5x CRWV's 20.32%. David Dodd would verify capital allocation.
6.62%
Diluted share reduction exceeding 1.5x CRWV's 20.32%. David Dodd would verify capital allocation.